Login

Financial Snapshot

Revenue
TTM
$254.9M
Gross Margin
TTM
42.96%
Net Income
TTM
-$20.03M
Current Assets
2023 Q1
Current Liabilities
2023 Q1
Current Ratio
2023 Q1
564.14%
Total Assets
2023 Q1
Total Liabilities
2023 Q1
Book Value
2023 Q1
$417.7M
Cash
2023 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$14.44M

Stock Price

Loading...
Market Cap: $1.3095 Billion

About HESKA CORP

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. The company is headquartered in Loveland, Colorado and currently employs 808 full-time employees. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The firm has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.

Industry: In Vitro & In Vivo Diagnostic Substances Peers: Abbott Laboratories Alphatec Holdings Inc CUTERA INC AngioDynamics Inc Butterfly Network Inc Outset Medical Inc LeMaitre Vascular Inc Mesa Laboratories Inc Varex Imaging Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support